SI1192184T1 - Estri surfakantnega proteina C - Google Patents

Estri surfakantnega proteina C

Info

Publication number
SI1192184T1
SI1192184T1 SI200030941T SI200030941T SI1192184T1 SI 1192184 T1 SI1192184 T1 SI 1192184T1 SI 200030941 T SI200030941 T SI 200030941T SI 200030941 T SI200030941 T SI 200030941T SI 1192184 T1 SI1192184 T1 SI 1192184T1
Authority
SI
Slovenia
Prior art keywords
surfactant protein
esters
respiratory distress
distress syndrome
treatment
Prior art date
Application number
SI200030941T
Other languages
English (en)
Inventor
Wolfgang Ise
Walther Gernandt
Dietrich Hafner
Wolf-Rudiger Ulrich
Ernst Sturm
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of SI1192184T1 publication Critical patent/SI1192184T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
SI200030941T 1999-06-17 2000-06-02 Estri surfakantnega proteina C SI1192184T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99111728 1999-06-17
PCT/EP2000/005031 WO2000078810A1 (en) 1999-06-17 2000-06-02 Surfactant protein c esters
EP00935162A EP1192184B1 (en) 1999-06-17 2000-06-02 Surfactant protein c esters

Publications (1)

Publication Number Publication Date
SI1192184T1 true SI1192184T1 (sl) 2007-06-30

Family

ID=8238379

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030941T SI1192184T1 (sl) 1999-06-17 2000-06-02 Estri surfakantnega proteina C

Country Status (12)

Country Link
US (2) US7022671B1 (sl)
EP (1) EP1192184B1 (sl)
JP (1) JP4762466B2 (sl)
AT (1) ATE350399T1 (sl)
AU (1) AU5074400A (sl)
CA (1) CA2375214C (sl)
DE (1) DE60032769T2 (sl)
DK (1) DK1192184T3 (sl)
ES (1) ES2278609T3 (sl)
PT (1) PT1192184E (sl)
SI (1) SI1192184T1 (sl)
WO (1) WO2000078810A1 (sl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
ATE163013T1 (de) 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
CA2063273C (en) 1989-07-11 2002-09-24 Bradley J. Benson Surfactant compositions and methods
EP0458167B1 (en) 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
JP3856343B2 (ja) 1995-11-20 2006-12-13 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 肺胞界面活性物質ペプチドの可溶化法

Also Published As

Publication number Publication date
CA2375214A1 (en) 2000-12-28
ES2278609T3 (es) 2007-08-16
JP4762466B2 (ja) 2011-08-31
EP1192184A1 (en) 2002-04-03
DE60032769T2 (de) 2007-11-22
JP2003502441A (ja) 2003-01-21
US20060148701A1 (en) 2006-07-06
US7022671B1 (en) 2006-04-04
AU5074400A (en) 2001-01-09
WO2000078810A1 (en) 2000-12-28
PT1192184E (pt) 2007-03-30
US7173009B2 (en) 2007-02-06
DE60032769D1 (de) 2007-02-15
ATE350399T1 (de) 2007-01-15
CA2375214C (en) 2012-01-17
DK1192184T3 (da) 2007-04-30
EP1192184B1 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
MY107843A (en) Anti-viral compounds.
HUP0200309A3 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
AU5936400A (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
YU57701A (sh) Veštački peptidi koji imaju površinsku aktivnost i njihova upotreba u pripremi veštačkog surfaktanta
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
WO2005018605A3 (en) Novel formulation of ropinirole
AU1006492A (en) Method for treatment for pulmonary disease
MY111871A (en) Heterocyclic compounds.
HU912013D0 (en) Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
HUP0203716A2 (hu) Tumorellenes hatású szubsztituált (N-benzil-indol-3-il)-glioxilsav-származékok, ezeket tartalmazó gyógyszerkészítmények
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
TW240170B (sl)
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
SI1192184T1 (sl) Estri surfakantnega proteina C
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
AU3922900A (en) Use of (valeriana) for the treatment of restless leg syndrome and related disorders
PL353992A1 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use